Integrin α5-induced EGFR activation by prothrombin triggers hepatocyte apoptosis via the JNK signaling pathway

Journal of Cellular Physiology

Volumn 216, Issue 2, 2008, Pages 551-557

  Wang, Ziqiu ^a,b   Wang, Meifang ^a   Carr, Brian I ^a,b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA5 INTEGRIN; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; CASPASE 3; EPIDERMAL GROWTH FACTOR RECEPTOR; FIBRONECTIN RECEPTOR; PROTEIN SHC; PROTHROMBIN; STRESS ACTIVATED PROTEIN KINASE; TYROSINE; ENZYME INHIBITOR; EPIDERMAL GROWTH FACTOR; THROMBIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL SHAPE; CONTROLLED STUDY; ENZYME ACTIVATION; GROWTH INHIBITION; IMMUNOPRECIPITATION; LIVER CELL; LIVER CELL CULTURE; MALE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ANIMAL; CYTOLOGY; FISCHER 344 RAT; GENETICS; HUMAN; METABOLISM; PHYSIOLOGY;

RATTUS;

ANIMALS; APOPTOSIS; ENZYME ACTIVATION; ENZYME INHIBITORS; EPIDERMAL GROWTH FACTOR; HEPATOCYTES; HUMANS; IN SITU NICK-END LABELING; INTEGRIN ALPHA5; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MALE; PROTHROMBIN; RATS; RATS, INBRED F344; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; THROMBIN;

EID: 46049111212     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21429     Document Type: Article

References (34)

1. Bill HM, Knudsen B, Moores SL, Muthuswamy SK, Rao VR, Brugge JS, Miranti CK. 2004. Epidermal growth factor receptor-dependent regulation of integrin-mediated signaling and cell cycle entry in epithelial cells. Mol Cell Biol 24:8586-8599.
2. Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
3. Cabodi S, Moro L, Erba EB, Di Stefano P, Turco E, Tarone G., et al. 2004. Integrin regulation of epidermal growth factor (EGF) receptor and of EGF-dependent responses. Biochem Soc Trans 32:438-442.
4. Carr BI, Kar S, Wang M, Wang Z. 2007. Growth inhibitory actions of prothrombin on normal hepatocyte: Influence of matrix. Cell Biol Int 31:929-938.
5. Chang L, Karin M. 2001. mammalian MAP kinase signaling cascades. Nature 410:37-40.
6. Giancotti FG, Ruoslahti E. 1999. Integrin signaling. Science 285:1028-1032.
7. Gong J, Ko TC, Brattain MG. 1998. Disruption of fibronectin binding to the α5b1 integrin stimulates the expression of cyclin-dependent kinases and DNA synthesis through activation of extracellular signal-regulated kinase. J Biol Chem 273:1662-1669.
8. Hayakawa J, Ohmichi M, Kurachi H, Ikegami H, Kimura A, Matsuoka T, Jikihara H, Mercola D, Murata Y. 1999. Inhibition of extracellular signal-regulated protein kinase or c-Jun N-terminal protein kinase cascade, differentially activated by cisplantin, sensitizes human ovarian cancer cell line. J Biol Chem 274:31648-31654.
9. Hitomi M, Yokoyama F, Kita Y, Nonomura T, Masaki T, Yoshiji H, Inoue H, Kinekawa F, Kurokohchi K, Uchida N, Watanabe S, Kuriyama S. 2005. Antitumor effects of vitamins K1, K2 and K3 on hepatocellular carcinoma in vitro and in vivo. Int J Oncol 26:713-720.
10. Huisse MG, Leclercq M, Belghiti J, Flejou JF, Suttie JW, Bezeaud A, Stafford DW, Guillin MC, 1994. Mechanism of the abnormal vitamin K-dependent gamma carboxylation process in human hepatocellular carcinomas. Cancer 74:1533-1541.
11. Hwang HS, Kim DW, Kim SS. 2006. Structure-activity relationships of the human prothrombin kringle-2 peptide derivative NS A9: Anti-proliferative activity and cellular internalization. Biochem J 395:165-172.
12. Ip YT, Davis RJ. 1998. Signal transduction by the c-Jun N-terminal kinase (JNK) - From inflammation to development. Curr Opin Cell Biol 10:205-219.
13. Jones PL, Crack J, Rabinovitch M. 1997. Regulation of tenascin-C, a vascular smooth muscle cell survival factor that interacts with the alpha v beta 3 integrin to promote epidermal growth factor receptor phosphorylation and growth. J Cell Biol 139: 279-293.
14. Kar S, Wang M, Carr BI. 2007. α-Thrombin inhibits DNA synthesis in rat hepatocytes but not in hepatoma cells by receptor activation and proteolysis. Mol Cell Biochem 304:189-197.
15. Miyamoto S, Teramoto H, Gutkind JS, Yamada KM. 1996. Integrins can collaborate with growth factors for phosphorylation of receptor tyrosine kinases and MAP kinase activation: Roles of integrin aggregation and occupancy of receptors. J Cell Biol 135:1633-1642.
16. Moro L, Venturino M, Bozzo C, Silengo L, Altruda F, Beguinot L., Tarone G, Defilippi P. 1998. Integrins induce activation of EGF receptor: Role in MAP kinase induction and adhesion-dependent cell survival. EMBO J 17:6622-6632.
17. Moro L, Dolce L, Cabodi S, Bergatto E, Erba EB, Smeriglio M, Turco E, Retta SF, Giuffrida MG, Venturino M, Godovac-Zimmermann J, Conti A, Schaefer E, Beguinot L, Tacchetti C, Gaggini P, Silengo L, Tarone G, Defilippi P. 2002. Integrin-induced epidermal growth factor (EGF) receptor activation requires c-Src and p130Cas and leads to phosphorylation of specific EGF receptor tyrosines. J Biol Chem 277:9405-9414.
18. Nishikawa Y, Carr BI, Wang M, Kar S, Finn F, Dowd P, Zheng ZB, Kerns J, Naganathan S. 1995. Growth inhibition of hepatoma cells induced by vitamin K and its analogs. J Biol Chem 270:28304-28310.
19. Potapova O, Haghighi A, Bost F, Liu C, Birrer MJ, Gjerset R, Mercola D. 1997. The Jun kinase/stress-activated protein kinase pathway functions to regulate DNA repair and inhibition of the pathway sensitizes tumor cells to cisplatin. J Biol Chem 272:14041-14044.
20. Schlaepfer DD, Hauck CR, Sieg DJ. 1999. Signaling through focal adhesion kinase. Prog Biophys Mol Biol 71:435-478.
21. Sechler JL, Schwarzbauer JE. 1998. Control of cell cycle progression by fibronectin matrix architecture. J Biol Chem 273:25533-25536.
22. Song JJ, Lee YJ. 2007. Differential activation of the JNK signal pathway by UV irradiation and glucose deprivation. Cell Signal 19:563-572.
23. Suzuki M, Shiraha H, Fujikawa T, Takaoka N, Ueda N, Nakanishi Y, Koike K, Takaki A, Shiratori Y. 2005. Des-γ-carboxy prothrombin is a potential autologous growth factor for hepatocellular carcinoma. J Biol Chem 280:6409-6415.
24. Tournier C, Hess P, Yang DD, Xu J, Turner TK, Nimnual A, Bar-Sagi D, Jones SN, Flavell RA, Davis RJ. 2000. Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway. Science 288:870-874.
25. Treisman R. 1996. Regulation of transcription by MAP kinase cascades. Curr Opin Cell Biol 8:205-215.
26. Vuori K, Ruoslahti E. 1994. Association of insulin receptor substrate-1 with integrins. Science 266:1576-1578.
27. Wang Z, Wang M, Finn F, Carr BI. 1995. The growth inhibitory effects of vitamin K and their actions on gene expression. Hepatology 22:876-881.
28. Wang Z, Wang M, Carr BI. 2000. Involvement of hepatocyte epidermal growth factor receptor mediated activation of mitogen-activated protein kinase signaling pathways in response to growth inhibition by a novel K vitamin. J Cell Physiol 183:338-346.
29. RSK. J Biol Chem 278:11138-11144.
30. Wierzbicka-Patynowski I, Schwarzbauer JE. 2003. The ins and outs of fibronectin matrix assembly. J Cell Sci 116:3269-3276.
31. Woodard AS, Garcia-Gardena G, Leong M, Madri JA, Sessa WC, Lanquino LR. 1998. The synergistic activity of alphavbeta3 integrin and PDGF receptor increases cell migration. J Cell Sci 111:469-478.
32. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME. 1995. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270:1326-1331.
33. Zain J, Huang YQ, Feng X, Nierodzik ML, Li JJ, Karpatkin S. 2000. Concentration-dependent dual effect of thrombin on impaired growth/apoptosis or mitogenesis in tumor cells. Blood 95:3133-3138.
34. Zwick E, Hackel PO, Prenzel N, Ullrich A. 1999. The EGF receptor as central transducer of heterologous signalling systems. TiPS 20:408-412.